lncRNA SNHG8 promotes aggressive behaviors of nasopharyngeal carcinoma via regulating miR-656-3p/SATB1 axis

被引:20
|
作者
Tian, Xiaoyan [1 ]
Liu, Yuehui [1 ]
Wang, Zhi [1 ]
Wu, Shuhong [1 ]
机构
[1] Nanchang Univ, Affiliated Hosp 2, Dept Otorhinolaryngol Head & Neck Surg, 1 Minde St, Nanchang 330006, Jiangxi, Peoples R China
关键词
SNHG8; Nasopharyngeal carcinoma; miR-656-3p; SATB1; CANCER CELLS; INVASION; PROLIFERATION; MIGRATION; GROWTH; SATB1;
D O I
10.1016/j.biopha.2020.110564
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Long non-coding RNA (lncRNA) has been proposed to regulate tumorigenesis, however, the role of small nucleolar RNA host gene 8 (SNHG8) in nasopharyngeal carcinoma (NPC) remains unclear. Methods: Levels of SNHG8 in NPC tissues and cells were analyzed with real-time quantitative PCR method. Cell counting kit-8 assay, colony formation assay, wound-healing assay, and transwell invasion assay were performed to detect cell viability, migration, and invasion. Luciferase activity assay and RIP assay were performed to explore relationships among SNHG8, microRNA-656 - 3p (miR-656 - 3p), and special AT-rich sequence-binding protein 1 (SATB1). Results: We found SNHG8 level was increased expression in NPC tissues and cells.In vitro assays revealed that SNHG8 stimulates NPC cell proliferation, colony formation, cell migration, and cell invasion. In vivo assay confirmed knockdown of SNHG8 could hamper tumor growth. Furthermore, we showed SNHG8 serves as a sponge for miR-656 - 3p to regulate SATB1 expression, and participated in NPC progression. Conclusions: In summary, our work indicated the importance of SNHG8 in NPC progression, which provided novel treatment methods for NPC.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Circular RNA PIP5K1A promotes glycolysis and malignancy of non-small cell lung cancer via miR-656-3p/GBE1 axis under hypoxia
    Sun, Zhiguang
    Han, Jinsheng
    Wang, Jindong
    MOLECULAR & CELLULAR TOXICOLOGY, 2024, 20 (02) : 293 - 305
  • [42] Silenced lncRNA SNHG14 restrains the biological behaviors of bladder cancer cells via regulating microRNA-211-3p/ESM1 axis
    Rui Feng
    Zhongxing Li
    Xing Wang
    Guangcheng Ge
    Yuejun Jia
    Dan Wu
    Yali Ji
    Chenghao Wang
    Cancer Cell International, 21
  • [43] CHI3L1 promotes myocardial fibrosis via regulating lncRNA TUG1/miR-495-3p/ETS1 axis
    Yunpeng Sun
    Xue Shan
    Jiantao Guo
    Xuguang Liu
    Dashi Ma
    Apoptosis, 2023, 28 : 1436 - 1451
  • [44] CHI3L1 promotes myocardial fibrosis via regulating lncRNA TUG1/miR-495-3p/ETS1 axis
    Sun, Yunpeng
    Shan, Xue
    Guo, Jiantao
    Liu, Xuguang
    Ma, Dashi
    APOPTOSIS, 2023, 28 (9-10) : 1436 - 1451
  • [45] Circular RNA PIP5K1A promotes glycolysis and malignancy of non-small cell lung cancer via miR-656-3p/GBE1 axis under hypoxia
    Zhiguang Sun
    Jinsheng Han
    Jindong Wang
    Molecular & Cellular Toxicology, 2024, 20 : 293 - 305
  • [46] LncRNA SNHG1 knockdown attenuates lipopolysaccharide-induced acute lung injury via regulating miR199a-3p/ROCK2 axis
    Qian, Wei
    Han, Yan
    Jin, Yan
    Lei, Changjiang
    Lin, Xue
    GENERAL PHYSIOLOGY AND BIOPHYSICS, 2024, 43 (05) : 399 - 409
  • [47] LncRNA SNHG5 promotes chondrocyte proliferation and inhibits apoptosis in osteoarthritis by regulating miR-10a-5p/H3F3B axis
    Jiang, Housen
    Pang, Hui
    Wu, Peigang
    Cao, Zhenhao
    Li, Zhong
    Yang, Xuedong
    CONNECTIVE TISSUE RESEARCH, 2021, 62 (06) : 605 - 614
  • [48] LncRNA BBOX1-AS1 Contributes to the Development of Nasopharyngeal Carcinoma via miR-204-5p/MUC4 Axis
    Xiong, Jian
    Zhou, Lang
    Zhou, Yuanhong
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2023, 53 (03): : 366 - 379
  • [49] LncRNA PVT1 promotes neuroinflammation after intracerebral hemorrhage by regulating the miR-128-3p/TXNIP axis
    Gong, Fanyong
    Wei, Yiting
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2024,
  • [50] Triptolide inhibits esophageal squamous cell carcinoma progression by regulating the circNOX4/miR-153-3p/SATB1 signaling pathway
    Liang, Hanping
    Che, Weibi
    Peng, Fengyuan
    Chen, Huilong
    Xie, Xihao
    Wu, Bomeng
    THORACIC CANCER, 2024, 15 (07) : 538 - 549